1. Home
  2. OC vs IMVT Comparison

OC vs IMVT Comparison

Compare OC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

N/A

Current Price

$122.67

Market Cap

9.5B

Sector

Industrials

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

N/A

Current Price

$30.04

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OC
IMVT
Founded
1938
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
OC
IMVT
Price
$122.67
$30.04
Analyst Decision
Buy
Buy
Analyst Count
18
17
Target Price
★ $146.31
$48.88
AVG Volume (30 Days)
1.1M
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
★ 2.54%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.59
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$97.53
$21.43
52 Week High
$159.91
$45.42

Technical Indicators

Market Signals
Indicator
OC
IMVT
Relative Strength Index (RSI) 52.97 50.53
Support Level $116.32 $30.24
Resistance Level $130.24 $34.60
Average True Range (ATR) 5.46 1.21
MACD 1.58 0.46
Stochastic Oscillator 68.95 97.72

Price Performance

Historical Comparison
OC
IMVT

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: